OGXI Overview
Upcoming Projects (OGXI)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (OGXI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (OGXI)
-
Phase 2 data of OGX-427(Apatorsen) Borealis-2 trial for advanced or metastatic bladder cancer due fourth quarter 2016
Ticker: OGXI
Occurred on: Oct 25, 2016 -
OncoGenex (OGXI) Releases Phase 3 ENSPIRIT data of Custirsen for Advanced Non-Small Cell Lung Cancer (NSCLC)
Ticker: OGXI
Occurred on: Oct 13, 2016 -
OncoGenex Announces AFFINITY Phase 3 data: custirsen, in combination with cabazitaxel/prednisone failed to achieve its primary endpoint
Ticker: OGXI
Occurred on: Aug 16, 2016 -
Phase 2 PFS data of OGX-427, carboplatin and pemetrexed - SpuceTrial for Non-squamous, non-small cell lung cancer (NSCLC) due 1Q 2016
Ticker: OGXI
Occurred on: Jan 20, 2016
Strategic Initiatives (OGXI)
-
OncoGenex will cut 27% of its workforce and certain planned expenditures
Ticker: OGXI
Announcement Date: Feb 04, 2016